Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.46 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.46 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.46 |
| ▸ | GJA1 | P17302 | 1/20 | 0.45 |
| ▸ | GJB2 | P29033 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | TYR | P14679 | 3/20 | 0.43 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22869547 | 1.00 | MEN1 (0.50) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL22869810 | 0.97 | MEN1 (0.48) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL22869440 | 0.97 | MEN1 (0.48) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL24211442 | 0.97 | MEN1 (0.48) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL22869811 | 0.97 | MEN1 (0.48) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL22869557 | 0.96 | LGALS8 (0.52) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL22869798 | 0.96 | LGALS8 (0.52) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL24211582 | 0.96 | MEN1 (0.47) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL22869561 | 0.96 | LGALS8 (0.52) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL22869776 | 0.96 | MEN1 (0.47) | MEN1KMT2ALGALS8LGALS3LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220017557-A1 | HIGH-PURITY STEVIOL GLYCOSIDES | PURECIRCLE USA INC. | 2022-01-20 | — | — | US | disclosed |
| US-20210002318-A1 | HIGH-PURITY STEVIOL GLYCOSIDES | PURECIRCLE USA INC. (US) | 2021-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210002318-A1 | HIGH-PURITY STEVIOL GLYCOSIDES | TAS2R7, ADH1C, TAS2R42 | MEN1 3378/4885KMT2A 1150/4885LGALS8 3835/4885 |
| US-20220017557-A1 | HIGH-PURITY STEVIOL GLYCOSIDES | TAS2R7, ADH1C, SUCLG2 | MEN1 3263/4885KMT2A 1819/4885LGALS8 2852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.